A Double-Blind, Prospective, Randomized Comparison of 2 Doses of MitoQ and Placebo for the Treatment of Patients With Parkinson's Disease.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Mitoquinone (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Antipodean Pharmaceuticals
- 29 Aug 2011 New source identified and integrated (Australian New Zealand Clinical Trials Registry; ACTRN12606000218594).
- 24 Apr 2008 Results have been reported in an Antipodean Pharmaceuticals media release.
- 19 Apr 2008 Tolerability results have been presented at the 60th AAN.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History